TABLE 5.
Negative SARS-CoV-2 air sampling studies in health care settingsa
| Study settings | Design | Proportion of positive samples | Strengths (+) and limitations (−) |
|---|---|---|---|
|
Cheng et al., 2020 (
145)
Hong Kong Low- and high-risk (including ICU) |
6 pts in AIIR Air sampling: 50 liters/min for 20 min (1,000 liters), 10 cm from pts’ chin under an umbrella (air shelter) |
Air: 0/6 | (+) Increased proportion of exhaled air sampled under the umbrella (+) Sampling with and without mask-wearing (+) Detailed clinical data on pts |
|
Faridi et al., 2020 (
200)
Iran Mostly high-risk (ICU) |
44 hospitalized pts Air sampling: 1.5 liters/min for 1 h (90 liters) in shared pt rooms |
Air: 0/10 | (+) Detailed information on environment and interventions (−) Lack of clinical data on individual pts (−) Small volume of air sampled |
|
Li et al., 2020 (
201)
Wuhan, China Low- and high-risk (including ICU) |
Designated COVID-19 hospital with 800 severe cases (20 in ICU) Air sampling: 80 liters/min for 30 min (2,400 liters) in 45 areas (low, medium, and high risk) |
Air: 0/135 | (+) Three replicate samples at each location on separate days (−) 4-time-daily air disinfection (false negative) (−) Qualitative reverse transcriptase PCR |
|
Wu et al., 2020 (
147)
Wuhan, China Low- and high-risk (including ICU) |
Designated COVID-19 hospital Sampling in moderate-risk (buffer room for doffing) and high-risk (pt room) areas |
Air: 0/44 | (−) No description of pts (−) Unknown air sampling method (−) Open windows and UV light disinfection (potential false negatives) |
AIIR, airborne infection isolation rooms; ICU, intensive care unit; pt(s), patient(s); Sx, symptom(s).